Amphetamine use disorder is associated with striatum hypoactivation during anticipation of loss and reward.

amphetamine use disorder loss anticipation monetary incentive delay task reward anticipation striatum

Journal

Journal of psychopharmacology (Oxford, England)
ISSN: 1461-7285
Titre abrégé: J Psychopharmacol
Pays: United States
ID NLM: 8907828

Informations de publication

Date de publication:
Mar 2024
Historique:
medline: 18 3 2024
pubmed: 27 1 2024
entrez: 27 1 2024
Statut: ppublish

Résumé

Dysregulated ventral striatum function has been proposed as one important process occurring in individuals with substance use disorder. This study investigates the role of altered reward and loss anticipation, which is an important component of impaired decision-making, impulsivity, and vulnerability to relapse in individuals with amphetamine use disorder (AMP). To determine whether AMP is associated with blunted striatum, prefrontal cortex, and insula signals during win and loss anticipation. Participants with and without AMP (AMP+ Group main effects indicated that: (1) AMP+ exhibited lower bilateral caudate/putamen and left nucleus accumbens signal than AMP- across anticipation of wins and losses; and (2) AMP+ showed slower reaction times than AMP- during loss anticipation. Group*condition interactions demonstrated that AMP+ exhibited greater right amygdala signal than AMP- while anticipating large wins, a pattern that reversed when anticipating small losses. Left caudate/putamen attenuations in AMP+ during small loss anticipation were also evident. Groups did not differ in prefrontal or insula signals. AMP+ individuals have altered neural processing and response patterns during reward and loss anticipation, potentially reflecting impairments in dopamine function, which may influence their decision-making and reactions to different win/loss scenarios. These findings help to explain why AMP+ have difficulty with decision-making and exhibit a heightened focus on immediate rewards or punishments.

Sections du résumé

BACKGROUND UNASSIGNED
Dysregulated ventral striatum function has been proposed as one important process occurring in individuals with substance use disorder. This study investigates the role of altered reward and loss anticipation, which is an important component of impaired decision-making, impulsivity, and vulnerability to relapse in individuals with amphetamine use disorder (AMP).
AIMS UNASSIGNED
To determine whether AMP is associated with blunted striatum, prefrontal cortex, and insula signals during win and loss anticipation.
METHODS UNASSIGNED
Participants with and without AMP (AMP+
RESULTS UNASSIGNED
Group main effects indicated that: (1) AMP+ exhibited lower bilateral caudate/putamen and left nucleus accumbens signal than AMP- across anticipation of wins and losses; and (2) AMP+ showed slower reaction times than AMP- during loss anticipation. Group*condition interactions demonstrated that AMP+ exhibited greater right amygdala signal than AMP- while anticipating large wins, a pattern that reversed when anticipating small losses. Left caudate/putamen attenuations in AMP+ during small loss anticipation were also evident. Groups did not differ in prefrontal or insula signals.
CONCLUSIONS UNASSIGNED
AMP+ individuals have altered neural processing and response patterns during reward and loss anticipation, potentially reflecting impairments in dopamine function, which may influence their decision-making and reactions to different win/loss scenarios. These findings help to explain why AMP+ have difficulty with decision-making and exhibit a heightened focus on immediate rewards or punishments.

Identifiants

pubmed: 38279659
doi: 10.1177/02698811231222355
doi:

Substances chimiques

Amphetamines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

236-246

Déclaration de conflit d'intérêts

Declaration of conflicting interestsThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

April C May (AC)

Palo Alto Veterans Affairs Health Care System, Mental Illness Research and Education Clinical Centers (MIRECC), Palo Alto, CA, USA.
Department of Psychiatry and Behavioral Sciences, School of Medicine, Stanford University, Stanford, CA, USA.

Kaiping Burrows (K)

Laureate Institute for Brain Research, Tulsa, OK, USA.

Rayus Kuplicki (R)

Laureate Institute for Brain Research, Tulsa, OK, USA.

Martin P Paulus (MP)

Laureate Institute for Brain Research, Tulsa, OK, USA.
Oxley College of Health Sciences, University of Tulsa, Tulsa, OK, USA.

Jennifer L Stewart (JL)

Laureate Institute for Brain Research, Tulsa, OK, USA.
Oxley College of Health Sciences, University of Tulsa, Tulsa, OK, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH